These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24200350)

  • 41. Left atrial appendage closure.
    Singh IM; Holmes DR
    Curr Cardiol Rep; 2010 Sep; 12(5):413-21. PubMed ID: 20544311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit.
    Gangireddy SR; Halperin JL; Fuster V; Reddy VY
    Eur Heart J; 2012 Nov; 33(21):2700-8. PubMed ID: 23008509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LAA occluder device for stroke prevention: Data on WATCHMAN and other LAA occluders.
    Bergmann MW
    Trends Cardiovasc Med; 2017 Aug; 27(6):435-446. PubMed ID: 28461140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Percutaneous left atrial appendage occlusion with a Watchman device following recurrent stroke on warfarin and rivaroxaban in patient with paroxysmal atrial fibrillation.
    Spina R; Subbiah R; Markus R; Gunalingam B
    Heart Lung Circ; 2014 Feb; 23(2):171-3. PubMed ID: 24076164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Left atrial appendage occlusion in elderly].
    Amabile N; Elhadad S; Roig C; Sebag F; Charles P; Caussin C
    Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):444-449. PubMed ID: 30376971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Percutaneous Left Atrial Appendage Closure: Current Devices and Clinical Outcomes.
    Asmarats L; Rodés-Cabau J
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial Experience With High-Risk Patients Excluded From Clinical Trials: Safety of Short-Term Anticoagulation After Left Atrial Appendage Closure Device.
    Barakat AF; Hussein AA; Saliba WI; Bassiouny M; Tarakji K; Kanj M; Jaber W; Rodriguez LL; Grimm R; Hussain MS; Russman A; Uchino K; Wisco D; Rasmussen P; Bain M; Vargo J; Zuccaro G; Gottesman D; Lindsay BD; Wazni OM
    Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27225288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Le D; Morelli R; Badhwar N; Lee RJ
    Expert Rev Cardiovasc Ther; 2015; 13(8):907-14. PubMed ID: 26070218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: Percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: indications, patient selection, competences, organization, and operator training].
    Casu G; Gulizia MM; Molon G; Mazzone P; Audo A; Casolo G; Di Lorenzo E; Portoghese M; Pristipino C; Ricci RP; Themistoclakis S; Padeletti L; Tondo C; Berti S; Oreglia JA; Gerosa G; Zanobini M; Ussia GP; Musumeci G; Romeo F; Di Bartolomeo R
    G Ital Cardiol (Rome); 2016; 17(7-8):594-613. PubMed ID: 27571335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [ANMCO statement on prevention of thromboembolism in atrial fibrillation and role of the new oral anticoagulants].
    Colonna P; Abrignani MG; Colivicchi F; Verdecchia P; Alunni G; Bongo AS; Ceravolo R; Oliva F; Rakar S; Riccio C; Scherillo M; Valle R; Bovenzi F;
    G Ital Cardiol (Rome); 2013 Apr; 14(4):295-322. PubMed ID: 23567775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) trial.
    Holmes DR; Reddy VY; Buchbinder M; Stein K; Elletson M; Bergmann MW; Schmidt B; Saw J
    Am Heart J; 2017 Jul; 189():68-74. PubMed ID: 28625383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation.
    Pepe M; Suppressa P; Giuliano AF; Nestola PL; Bortone AS; DE Cillis E; Acquaviva T; Forleo C; Moscarelli M; Lenato GM; Sabbà C
    Minerva Cardiol Angiol; 2022 Oct; 70(5):537-544. PubMed ID: 33703853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey.
    Tilz RR; Potpara T; Chen J; Dobreanu D; Larsen TB; Haugaa KH; Dagres N
    Europace; 2017 Oct; 19(10):1737-1742. PubMed ID: 29016910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
    Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D
    Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurologic complications of atrial fibrillation: Pharmacologic and interventional approaches to stroke prevention.
    Bhirud A; Vasaiwala S
    Handb Clin Neurol; 2021; 177():143-149. PubMed ID: 33632432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
    Overvad TF; Larsen TB; Albertsen IE; Rasmussen LH; Lip GY
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1619-29. PubMed ID: 24215192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C; Vedovati MC; Agnelli G
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left atrial appendage closure is preferred to chronic warfarin therapy: the pro perspective.
    Atoui M; Gunda S; Lakkireddy D
    Card Electrophysiol Clin; 2015 Sep; 7(3):403-13. PubMed ID: 26304519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.